Merck stock surges 30% on strong fundamentals, regulatory catalysts, and attractive valuation. See why I rate the MRK stock a ...

Merck (MRK) ended the recent trading session at $111.01, demonstrating a +2.54% change from the preceding day's closing price ...

Merck has other promising candidates in its late-stage pipeline, such as enlicitide decanoate/MK-0616, an oral PCSK9 ...

Fintel reports that on January 8, 2026, Wolfe Research upgraded their outlook for Merck (NYSE:MRK) from Peer Perform to ...

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such ...

Merck (MRK) stock gains as Wolfe Research upgrades the company to Outperform, while AbbVie (ABBV) falls as the firm ...

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of ...

Merck (MRK) stock achieved a 5-day winning streak, with total gains during this time reaching 6.9%. The company’s market capitalization has jumped by approximately $17 billion over the past five days, ...

Merck (MRK) closed at $106.45 in the latest trading session, marking a +1.34% move from the prior day. This change outpaced the S&P 500's 0.32% gain on the day. Elsewhere, the Dow saw an upswing of ...

AbbVie’s neuroscience portfolio is also contributing to top-line growth. Sales of its neuroscience drugs increased 20.3% to ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Revolution Medicines (NASDAQ:RVMD) stock closed higher by 5% Thursday and added another 15% after-hours following a Financial Times report that Merck (NYSE:MRK) is in talks to acquire the biotech ...